Cancer begets venous thromboembolism, but is venous thromboembolism a risk factor for cancer?

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 4, 2009, Pages 543-545

  White, Richard H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PROSTATE SPECIFIC ANTIGEN; WARFARIN;

ANTIGEN DETECTION; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLONOSCOPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; KIDNEY CANCER; LIVER CANCER; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; METASTASIS POTENTIAL; NOTE; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; UTERUS CANCER; VENOUS THROMBOEMBOLISM;

HUMANS; NEOPLASMS; RISK FACTORS; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63049133464     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03281.x     Document Type: Note

References (25)

1. Bouillaud S. Obliteratioin des veines et de son influence sur la formation des hydropisies particelles: Considedration sur la hydropiesies passive et general. Arch Gen Med 1823; 1: 188-204.
2. Trousseau A. Phlegmasia alba dolens. Clinique Medicale de l'Hotel-Dieu de Paris 1865; 3: 654-712.
3. Gore JM, Appelbaum JS, Greene HL, Dexter L, Dalen JE. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 1982; 96: 556-60.
4. Prandoni P, Lensing AW, Buller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten Cate JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
5. Buller HR. Has time come for screening for occult cancer in patients with venous thromboembolism? J Thromb Haemost 2004; 2: 874-5.
6. Trujillo-Santos J, Prandoni P, Rivron-Guillot K, Roman P, Sanchez R, Tiberio G, Monreal M. Clinical outcome in patients with venous thromboembolism and hidden cancer: Findings from the RIETE Registry. J Thromb Haemost 2008; 6: 251-5.
7. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, Wun T. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 2005; 165: 1782-7.
8. Rickles FR. Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol Haemost Thromb 2006; 35: 103-10.
9. Monreal M, Lensing AW, Prins MH, Bonet M, Fernandez-Llamazares J, Muchart J, Prandoni P, Jimenez JA. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2004; 2: 876-81.
10. Khorana AA, Liebman HA, White RH, Wun T, Lyman GH. The Risk of Venous Thromboembolism in Patients with Cancer. Alexandria, VA: ASCO Educational Book 2008; 2008: 240-8.
11. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-64.
12. Osborne NH, Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol 2008; 15: 3567-78.
13. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008; 168: 2377-81.
14. Manzoni M, Bencardino K, Piovella F, Chatzileontiadou S, Delfanti S, Riccardi A, Danova M, Corazza GR. New agents in medical oncology and the risk of venous thromboembolism. J Exp Clin Cancer Res 2007; 26: 185-94.
15. Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. Systematic review: The TrousSeau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008; 149: 323-33.
16. Piccioli A, Lensing AW, Prins MH, Falanga A, Scannapieco GL, Ieran M, Cigolini M, Ambrosio GB, Monreal M, Girolami A, Prandoni P. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: A prospective randomized clinical trial. J Thromb Haemost 2004; 2: 884-9.
17. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
18. Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: A national, population-based cohort study. Br J Cancer 2004; 91: 92-5.
19. Douketis JD, Gu C, Piccioli A, Ghirarduzzi A, Pengo V, Prandoni P. The long-term risk of cancer in patients with a first episode of venous thrombeombolism. J Thromb Haemost 2009; 7: 546-51.
20. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.
21. Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M. Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost 2003; 1: 1730-3.
22. Tagalakis V, Tamim H, Blostein M, Collet J-P, Hanley JA, Kahn SR. Use of warfarin and risk of urogenital cancer: A population-based, nested case-control study. Lancet Oncol 2007; 8: 395-402.
23. Cunningham MS, Preston RJ, O'Donnell JS. Does antithrombotic therapy improve survival in cancer patients? Blood Rev 2008; doi:.
24. Lee AY. Cancer and venous thromboembolism: Prevention, treatment and survival. J Thromb Thrombolysis 2008; 25: 33-6.
25. Hurwitz LM, Reiman RE, Yoshizumi TT, Goodman PC, Toncheva G, Nguyen G, Lowry C. Radiation dose from contemporary cardiothoracic multidetector CT protocols with an anthropomorphic female phantom: Implications for cancer induction. Radiology 2007; 245: 742-50.